ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 168 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $68,576 | -31.4% | 21,633 | +7.5% | 0.00% | – |
Q2 2023 | $100,016 | +4.4% | 20,124 | +3.7% | 0.00% | – |
Q1 2023 | $95,826 | -31.3% | 19,398 | -12.5% | 0.00% | – |
Q4 2022 | $139,518 | -38.0% | 22,181 | +6.2% | 0.00% | -100.0% |
Q3 2022 | $225,000 | -7.4% | 20,884 | -2.2% | 0.00% | 0.0% |
Q2 2022 | $243,000 | -8.6% | 21,359 | -26.9% | 0.00% | 0.0% |
Q1 2022 | $266,000 | -51.5% | 29,221 | -20.5% | 0.00% | 0.0% |
Q4 2021 | $549,000 | -47.7% | 36,775 | -9.9% | 0.00% | -66.7% |
Q3 2021 | $1,050,000 | -11.5% | 40,837 | -10.2% | 0.00% | 0.0% |
Q2 2021 | $1,186,000 | -4.3% | 45,476 | +29.5% | 0.00% | -25.0% |
Q1 2021 | $1,239,000 | +41.1% | 35,111 | +1.0% | 0.00% | +33.3% |
Q4 2020 | $878,000 | -22.8% | 34,779 | +15.3% | 0.00% | -40.0% |
Q3 2020 | $1,137,000 | -4.0% | 30,152 | +9.0% | 0.01% | -16.7% |
Q2 2020 | $1,184,000 | +204.4% | 27,659 | +38.4% | 0.01% | +100.0% |
Q1 2020 | $389,000 | -54.4% | 19,992 | -39.1% | 0.00% | -25.0% |
Q4 2019 | $853,000 | – | 32,842 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $26,829,000 | 10.04% |
Wildcat Capital Management, LLC | 1,716,370 | $25,608,000 | 4.17% |
TPG GP A, LLC | 18,716,306 | $279,247,000 | 2.79% |
Casdin Capital, LLC | 2,650,000 | $39,538,000 | 1.11% |
Lombard Odier Asset Management (Switzerland) SA | 996,116 | $14,862,000 | 0.95% |
Coastal Bridge Advisors, LLC | 301,929 | $4,505,000 | 0.94% |
HARBOR CAPITAL ADVISORS, INC. | 119,547 | $1,784,000 | 0.65% |
Pier Capital, LLC | 294,968 | $4,401,000 | 0.46% |
Navalign, LLC | 64,428 | $961,000 | 0.38% |
Gratus Capital, LLC | 191,871 | $2,863,000 | 0.26% |